|Your company can benefit
from enhanced listings. Questions? Read our FAQ
Personalized notification service and newsletter info
|Subscribe (free) to get notified
of new additions.
Learn more About us and about our Services
FibroGen is a privately held biotechnology company dedicated to the discovery, development and commercialization of innovative treatments for fibroproliferative disorders, such as deep organ fibrosis and complications arising from surgical scarring, as well as therapies related to tissue repair and regeneration. FibroGen is also the world leader in the development and production of human recombinant collagen and gelatin for use in the medical device, pharmaceutical and fine chemical markets.
Product / Technology type(s) covered:
United States of America
b. Continent(s) active:
c. Countries active:
Number of Employees:
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page last modified: .